OTC: HTSUF - Hisamitsu Pharmaceutical Co., Inc.

Rentabilität für sechs Monate: 0%
Dividendenrendite: +174.36%
Sektor: Healthcare

Aktionsplan Hisamitsu Pharmaceutical Co., Inc.

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.

weitere details
The company exports its products to approximately 40 countries and regions, including Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета jpy
Див.доход ао 174.36
Дивиденд ао 0.3211
Сайт https://www.hisamitsu.co.jp
Цена ао 24.56
Preisänderung pro Tag: 0% (24.559)
Preisänderung pro Woche: 0% (24.559)
Preisänderung pro Monat: 0% (24.559)
Preisänderung über 3 Monate: 0% (24.559)
Preisänderung über sechs Monate: 0% (24.559)
Preisänderung pro Jahr: -4.72% (25.775)
Preisänderung seit Jahresbeginn: 0% (24.559)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 2.78 6
P/BV 1.48 9
P/E 28.21 6
EV/EBITDA 15.47 6
Gesamt: 5.88

Effizienz

Name Bedeutung Grad
ROA, % 4.35 1
ROE, % 5.36 2
Gesamt: 2.17

Dividenden

Name Bedeutung Grad
Div yield, % 174.36 10
DSI 0.8571 8.57
Gesamt: 6.58

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0.1145 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 0.5064 1
Rentabilität Ebitda, % -38.66 0
Rentabilität EPS, % 332.13 10
Gesamt: 2.2
Weitere Details

Weitere Details

Institutionen Volumen Aktie, %
Vanguard International Stock Index-Total Intl Stock Indx 915894 1.08
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 542663 0.64
iShares Core MSCI EAFE ETF 268000 0.31
iShares MSCI EAFE Small Cap ETF 200300 0.24
Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund 133296 0.16
Schwab Strategic Tr-Schwab International Equity ETF 116660 0.14
Schwab Strategic Tr-Schwab Fundamental Intl Small Company Idx ETF 82913 0.1
Old Westbury Small & Mid Cap Strategies Fund 80900 0.09
Vanguard International Stock Index-Pacific Stock Index 80803 0.09
DFA International Core Equity Portfolio 70700 0.08



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Kazuhide Nakatomi President, CEO & Director N/A 1972 (53 Jahr)
Mr. Nobuo Tsutsumi GM of Legal Dept, Prod Environment, Reliability Assurance & Comp Manager, Executive Off and Dir N/A 1964 (61 Jahr)
Kazunori Ito Executive Officer & GM of Human Resources Department N/A
Mr. Kyu Saito MD, Executive Officer, GM of Global Business & Director N/A 1963 (62 Jahr)
Mr. Shinichi Murayama Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director N/A 1967 (58 Jahre)
Mitsutoshi Tsuruta Executive Officer & Head of Ethical Division N/A
Masaya Okuno Executive Officer and Head of Sales & Marketing Division, OTC N/A
Mr. Koji Takiyama Executive Officer, GM of President's Office & Director N/A 1971 (54 Jahr)
Katsuhiko Akiyama Sr. Exe. Officer & GM of MN Commercialization Office N/A

Adresse: Japan, Tosu, Tashirodaikan-machi 408 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.hisamitsu.co.jp